Vir Biotechnology

-$0.29 (-0.74%) Today
+$0.15 (+0.39%) As of 10:11 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.

About VIR

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.

CEO
George A. Scangos
Employees
327
Headquarters
San Francisco, California
Founded
2016

VIR Key Statistics

Market Cap
5.07B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.17M
High Today
$39.47
Low Today
$38.58
Open Price
$38.64
Volume
569.95K
52 Week High
$141.01
52 Week Low
$25.31

VIR Earnings

-$1.32
-$0.73
-$0.13
$0.46
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure